Aggressive natural killer-cell leukemia revisited: large granular lymphocyte leukemia of cytotoxic NK cells
Top Cited Papers
- 12 February 2004
- journal article
- research article
- Published by Springer Science and Business Media LLC in Leukemia
- Vol. 18 (4), 763-770
- https://doi.org/10.1038/sj.leu.2403262
Abstract
Aggressive natural killer-cell leukemia (ANKL) is a rare form of large granular lymphocyte leukemia, which is characterized by a systemic proliferation of NK cells. The clinical features of 22 ANKL cases were analyzed. Hepatomegaly (64%), splenomegaly (55%) and lymphadenopathy (41%) were also frequently observed. Leukemic cells were identified as CD1-, CD2+, surface CD3-, CD4-, CD5-, CD7+, CD8+/-, CD10-, CD11b+/-, CD13-, CD16+, CD19-, CD20-, CD25-, CD33-, CD34-, CD38+, CD56+, CD122+, HLA-DR+ and TCR-. Two of the 16 cases examined for CD57 were positive and three of the seven cases examined for cytoplasmic CD3. Epstein–Barr virus was detected in the tumor cells of 11 of the 13 cases examined. No common cytogenetic abnormalities were identified and 6q anomaly was detected in only one. Three of 13 patients treated with chemotherapy containing anthracycline/anthraquinone attained complete remission, in contrast to none of the eight who were treated with regimens without anthracycline. Although the overall prognosis was poor with a median survival of 58 days, those who attained remission showed better prognosis (P=0.005). These findings suggest that ANKL is an entity of mature cytotoxic NK-cell neoplasms with distinct phenotype and disease presentations. Intensive treatment for ANKL may result in a better prognosis.Keywords
This publication has 47 references indexed in Scilit:
- Molecular Analysis of Tumor Suppressor Genes, Rb, p53,pl6INK4A, pl5INK4B and p14ARF in Natural Killer Cell NeoplasmsJapanese Journal of Cancer Research, 2001
- Epstein-Barr Virus-Infected Natural Killer Cell LeukemiaLeukemia & Lymphoma, 2000
- Comparative Genomic Hybridization Analysis of Natural Killer Cell Lymphoma/Leukemia: Recognition of Consistent Patterns of Genetic AlterationsThe American Journal of Pathology, 1999
- Successful treatment of Epstein–Barr virus-associated natural killer cell large granular lymphocytic leukaemia using allogeneic peripheral blood stem cell transplantationBone Marrow Transplantation, 1998
- The detection of clonal proliferation in granular lymphocyte‐proliferative disorders of natural killer cell lineageBritish Journal of Haematology, 1995
- Hemophagocytic syndrome associated with aggressive natural killer cell leukemiaAmerican Journal of Hematology, 1991
- CYTOKINE LEVELS IN AGGRESSIVE NATURAL KILLER CELL LEUKAEMIA AND MALIGNANT HISTIOCYTOSISBritish Journal of Haematology, 1991
- Functional consequences of interleukin 2 receptor expression on resting human lymphocytes. Identification of a novel natural killer cell subset with high affinity receptors.The Journal of Experimental Medicine, 1990
- Chromosomal abnormalities define clonal proliferation in CD3‐ large granular lymphocyte leukemiaAmerican Journal of Hematology, 1990
- CD3-negative lymphoproliferative disease of granular lymphocytes containing Epstein-Barr viral DNA.JCI Insight, 1989